Stock
Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned
US listed securityListed on NASDAQ
US headquarteredHeadquartered in Massachusetts, United States
addFollow
Moderna Inc
$129.65
MRNA
After Hours:(arrow_downward-0.17%)-$0.22
$129.43
Closed: Jan 15, 7:59:33 PM GMT-5 · USD · NASDAQ · Disclaimer
In the news
Financial performance
| (USD) | Q3 2020 | Year/year change |
|---|---|---|
Revenue | 157.91M | arrow_upward826.38% |
Net income | -233.64M | arrow_downward-89.62% |
| Diluted EPS | - | - |
| Net profit margin | -147.96% | arrow_upward79.53% |
| Operating income | -235.12M | arrow_downward-79.80% |
| Net change in cash | -255.79M | arrow_downward-1,258.14% |
| Cash on hand | 1.51B | arrow_upward766.72% |
| Cost of revenue | 344.49M | arrow_upward187.94% |
About
Moderna is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.
Moderna's technology platform inserts synthetic nucleoside-modified mRNA into human cells. This mRNA then reprograms the cells to prompt immune responses. It is a novel technique, previously abandoned due to the side effects of inserting mRNA into cells. As of November 2020, the Moderna COVID-19 vaccine candidate, mRNA-1273, had shown preliminary evidence of 94% efficacy in preventing COVID-19 disease in a Phase III trial, with only minor flu-like side effects. This led to its submission for emergency use authorization in Europe, the United States, and Canada. On December 18, 2020, mRNA-1273 was issued an EUA in the United States. It was authorized for use in Canada on December 23, 2020, as well as in the European Union on January 6, 2021. Subsequently the mRNA-1273 was authorized in the United Kingdom on 8 January 2021. Wikipedia
Founded
Sep 2010
Headquarters
Website
Employees
1,100
Key stats
Previous close
The last closing price
$129.72
Day range
The difference between the high and low prices over the past day
$126.58 - $133.29
Year range
The difference between the high and low prices over the past 52 weeks
$17.91 - $178.50
Market cap
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.
51.30B USD
Volume
The average number of shares traded each day over the past 30 days
26.12M
P/E ratio
The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks
-
Dividend yield
The ratio of annual dividend to current share price that estimates the dividend return of a stock
-
Primary exchange
Listed exchange for this security
NASDAQ
About
Moderna is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.
Moderna's technology platform inserts synthetic nucleoside-modified mRNA into human cells. This mRNA then reprograms the cells to prompt immune responses. It is a novel technique, previously abandoned due to the side effects of inserting mRNA into cells. As of November 2020, the Moderna COVID-19 vaccine candidate, mRNA-1273, had shown preliminary evidence of 94% efficacy in preventing COVID-19 disease in a Phase III trial, with only minor flu-like side effects. This led to its submission for emergency use authorization in Europe, the United States, and Canada. On December 18, 2020, mRNA-1273 was issued an EUA in the United States. It was authorized for use in Canada on December 23, 2020, as well as in the European Union on January 6, 2021. Subsequently the mRNA-1273 was authorized in the United Kingdom on 8 January 2021. Wikipedia
Founded
Sep 2010
Headquarters
Website
Employees
1,100
